ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCA Okays Only A committee For Centers, Not New Division

May 29, 1987

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

June 5, 1987

ACS Says 41 Percent Survive 5 Years

January 2, 1981

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011

Exercisers May Have Higher Breast Cancer Survival

October 27, 2006

NCAB Approves Call For New Efforts In Black/Hispanic Cancer

February 6, 1981